Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

NaHCO 3 Dilates Mouse Afferent Arteriole Via Na + /HCO 3 - Cotransporters NBCs.

Tytuł:
NaHCO 3 Dilates Mouse Afferent Arteriole Via Na Cotransporters NBCs.
Autorzy:
Jiang S; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Wang X; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).; Shandong Provincial Hospital, Affiliated Hospital of Shandong University, Jinan, China (X.W.).
Wei J; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Zhang G; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Zhang J; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Xie P; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).
Xu L; College of Public Health, University of South Florida, Tampa (L.X.).
Wang L; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Zhao L; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).; Department of Physiology, School of Basic Medical Sciences, Guangzhou Medical University, China (L.Z., E.Y.L.).; Institute of Vegetative Physiology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Germany (L.Z., E.Y.L.).
Li L; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).; Division of Nephrology and Hypertension, and Hypertension Center, Georgetown University, Washington, DC (L.L., C.S.W.).
Wilcox CS; Division of Nephrology and Hypertension, and Hypertension Center, Georgetown University, Washington, DC (L.L., C.S.W.).
Chen J; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).
Lai EY; From Kidney Disease Center, the First Affiliated Hospital, and Department of Physiology, School of Basic Medical Sciences, Zhejiang University School of Medicine, Hangzhou, China (S.J., G.Z., P.X., L.Z., L.L., J.C., E.Y.L.).; Department of Physiology, School of Basic Medical Sciences, Guangzhou Medical University, China (L.Z., E.Y.L.).; Institute of Vegetative Physiology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Germany (L.Z., E.Y.L.).
Liu R; Department of Molecular Pharmacology and Physiology, University of South Florida College of Medicine, Tampa (S.J., X.W., J.W., G.Z., J.Z., L.W., R.L.).
Źródło:
Hypertension (Dallas, Tex. : 1979) [Hypertension] 2019 Nov; Vol. 74 (5), pp. 1104-1112. Date of Electronic Publication: 2019 Sep 16.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: : Hagerstown, MD : Lippincott, Williams & Wilkins
Original Publication: [Dallas, Tex.] : [American Heart Association], [©1979]-
MeSH Terms:
Arterioles/*drug effects
Kidney Glomerulus/*drug effects
Sodium Bicarbonate/*pharmacology
Sodium-Bicarbonate Symporters/*metabolism
Vasodilation/*drug effects
Animals ; Arterioles/physiology ; Disease Models, Animal ; Glomerular Filtration Rate/drug effects ; Male ; Mice ; Mice, Inbred C57BL ; Nitric Oxide/metabolism ; Perfusion/methods ; Renal Insufficiency, Chronic/drug therapy ; Renal Insufficiency, Chronic/pathology ; Sensitivity and Specificity ; Sodium-Bicarbonate Symporters/drug effects ; Tissue Culture Techniques ; Vasodilation/physiology
References:
Circ Res. 1994 Jun;74(6):1220-6. (PMID: 7514511)
Am J Physiol Renal Physiol. 2008 Sep;295(3):F851-6. (PMID: 18667487)
J Am Soc Nephrol. 2009 Sep;20(9):2075-84. (PMID: 19608703)
Gend Med. 2012 Apr;9(2):103-11. (PMID: 22445695)
Physiol Rev. 2013 Apr;93(2):803-959. (PMID: 23589833)
Physiology (Bethesda). 2016 Sep;31(5):370-83. (PMID: 27511463)
Acta Physiol (Oxf). 2016 Oct;218(2):136-45. (PMID: 27362287)
Physiol Genomics. 2017 Oct 1;49(10):531-540. (PMID: 28842434)
Kidney Int. 2005 May;67(5):1837-43. (PMID: 15840031)
J Clin Invest. 1993 Oct;92(4):1981-5. (PMID: 8408651)
Am J Physiol Renal Physiol. 2015 May 1;308(9):F1020-5. (PMID: 25608966)
Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97. (PMID: 16870827)
Kidney Int. 2009 May;75(9):929-35. (PMID: 19190678)
Acta Physiol (Oxf). 2015 Jan;213(1):285-93. (PMID: 25394939)
Nitric Oxide. 2010 Dec 15;23(4):269-74. (PMID: 20682356)
Am J Physiol Heart Circ Physiol. 2001 Mar;280(3):H937-45. (PMID: 11179033)
Radiology. 2012 Dec;265(3):762-71. (PMID: 23023964)
Hypertension. 2010 Nov;56(5):907-13. (PMID: 20876452)
J Am Soc Nephrol. 2016 Aug;27(8):2346-56. (PMID: 26647426)
Life Sci. 2002 Aug 9;71(12):1439-47. (PMID: 12127164)
Nephrol Dial Transplant. 2006 Oct;21(10):2703-7. (PMID: 16854849)
Am J Physiol. 1988 Dec;255(6 Pt 1):C844-56. (PMID: 2849306)
Nitric Oxide. 2018 Sep 1;79:45-50. (PMID: 30063984)
Hypertension. 2017 Dec;70(6):1219-1227. (PMID: 29061720)
J Neurosci. 2009 Mar 11;29(10):3252-8. (PMID: 19279262)
Kidney Int. 2011 Feb;79(3):356-62. (PMID: 20962743)
Nephrol Dial Transplant. 2018 Jul 24;:null. (PMID: 30053298)
Acta Physiol (Oxf). 2017 Mar;219(3):652-659. (PMID: 27454938)
Circ Res. 1988 Sep;63(3):518-33. (PMID: 3409484)
Am J Physiol Regul Integr Comp Physiol. 2015 Oct;309(7):R757-66. (PMID: 26269519)
J Am Soc Nephrol. 2002 Nov;13(11):2688-96. (PMID: 12397038)
Am J Kidney Dis. 2005 Jun;45(6):978-93. (PMID: 15957126)
Kidney Int. 2014 Mar;85(3):529-35. (PMID: 24107852)
Curr Opin Nephrol Hypertens. 2019 May;28(3):267-277. (PMID: 30681417)
Circ Res. 2016 Jul 8;119(2):375-96. (PMID: 27390338)
J Clin Invest. 1959 Jan 1;38(1, Part 1):39-52. (PMID: 13620770)
J Physiol. 1993 Jul;466:1-8. (PMID: 8410686)
Pflugers Arch. 1991 Aug;419(1):51-6. (PMID: 1945761)
Mol Vis. 2013 May 24;19:1096-106. (PMID: 23734078)
Eur J Pharmacol. 2011 Apr 10;656(1-3):88-93. (PMID: 21300058)
Eur Heart J. 2012 Apr;33(7):829-37, 837a-837d. (PMID: 21890489)
J Am Soc Nephrol. 2019 Apr;30(4):578-593. (PMID: 30867247)
Circulation. 2011 Oct 25;124(17):1819-29. (PMID: 21947296)
Circ Res. 2006 Mar 3;98(4):515-23. (PMID: 16439691)
Am J Physiol Cell Physiol. 2018 May 1;314(5):C569-C588. (PMID: 29384695)
Hypertension. 2016 Apr;67(4):792-9. (PMID: 26883268)
Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F123-F129. (PMID: 29513069)
Curr Opin Nephrol Hypertens. 2007 Jan;16(1):46-51. (PMID: 17143071)
Nature. 2011 Sep 11;478(7367):103-9. (PMID: 21909115)
Clin J Am Soc Nephrol. 2013 May;8(5):714-20. (PMID: 23393105)
Acta Physiol (Oxf). 2015 Jan;213(1):249-58. (PMID: 25089004)
Miner Electrolyte Metab. 1990;16(5):331-40. (PMID: 2283996)
Cardiovasc Res. 2016 Aug 1;111(3):227-39. (PMID: 27076468)
J Cereb Blood Flow Metab. 2016 May;36(5):965-80. (PMID: 26661205)
Clin Exp Pharmacol Physiol. 2005 May-Jun;32(5-6):410-4. (PMID: 15854150)
Am J Physiol Renal Physiol. 2013 Dec 15;305(12):F1765-74. (PMID: 24005470)
Kidney Int. 2010 Aug;78(3):303-9. (PMID: 20445497)
Grant Information:
R01 DK099276 United States DK NIDDK NIH HHS; R01 HL137987 United States HL NHLBI NIH HHS; R01 HL142814 United States HL NHLBI NIH HHS
Contributed Indexing:
Keywords: arterioles; glomerular filtration rate; nitric oxide; sodium bicarbonate; vasodilation
Substance Nomenclature:
0 (Sodium-Bicarbonate Symporters)
31C4KY9ESH (Nitric Oxide)
8MDF5V39QO (Sodium Bicarbonate)
Entry Date(s):
Date Created: 20190917 Date Completed: 20191120 Latest Revision: 20201101
Update Code:
20240105
PubMed Central ID:
PMC6785401
DOI:
10.1161/HYPERTENSIONAHA.119.13235
PMID:
31522618
Czasopismo naukowe
Sodium bicarbonate has long been used to treat chronic kidney disease. It has been demonstrated to slow the decline in glomerular filtration rate in chronic kidney disease patient; however, the mechanisms are not completely understood. We hypothesized that NaHCO 3 dilates afferent arterioles (Af-Art) by stimulating nitric oxide (NO) release mediated by the Na + /HCO 3 - cotransporter (NBC) contributing to the elevation in glomerular filtration rate. Isolated microperfused mouse renal Af-Art, preconstricted with norepinephrine (1 µmol/L), dilated 45±2% (n=6, P <0.05) in response to NaHCO 3 (44 mmol/L). Whereas, NaCl solution containing the same Na + concentration was not effective. The mRNA for NBCn1 and NBCe1 were detected in microdissected Af-Art using reverse transcription-polymerase chain reaction and quantitative polymerase chain reaction. The Af-Art intracellular pH measured with 2',7'-bis-(2-carboxyethyl)-5-(and-6) carboxyfluorescein, acetoxymethyl ester increased significantly by 0.29±0.02 (n=6; P <0.05) in the presence of NaHCO 3 , which was blunted by N-cyanosulphonamide compound (S0859) that is an inhibitor of the NBC family. After clamping the intracellular pH with 10 μM nigericin, changing the bath solution pH from 7.4 to 7.8 still dilates the Af-Art by 53±4% (n=7; P <0.005) and increases NO generation by 22±3% (n=7; P <0.005). Both pH-induced NO generation and vasodilation were blocked by L-NG-Nitroarginine Methyl Ester. NaHCO 3 increased NO generation in Af-Art by 19±4% (n=5; P <0.005) and elevated glomerular filtration rate in conscious mice by 36% (233 versus 318 ul/min; n=9-10; P <0.0001). S0859 and L-NG-nitroarginine methyl ester blocked NaHCO 3 -induced increases in NO generation and vasodilation. We conclude that NBCn1 and NBCe1 are expressed in Af-Art and that NaHCO 3 dilates Af-Art via NBCs mediated by NO that increases the glomerular filtration rate.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies